{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/61755-019#drug","name":"Inmazeb","alternateName":"atoltivimab, maftivimab, and odesivimab-ebgn","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"61755-019"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA761169"},{"@type":"PropertyValue","propertyID":"UNII","value":"UY9LQ8P6HW|KOP95331M4|FJZ07Q63VY"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"0536b6fe-6fe5-4fd6-8cc6-1b481945c1fa"}],"activeIngredient":"ATOLTIVIMAB, MAFTIVIMAB, ODESIVIMAB","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, SOLUTION","manufacturer":{"@type":"Organization","name":"Regeneron Pharmaceuticals, Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA761169","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0536b6fe-6fe5-4fd6-8cc6-1b481945c1fa","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61755-019"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T08:47:09.202Z"}}